Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
5.4
3.9
Journals
JCM
Special Issues
Hypertension and Cardiovascular Disease: Clinical Updates and Perspectives
share announcement

Hypertension and Cardiovascular Disease: Clinical Updates and Perspectives

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Cardiovascular Medicine".

Deadline for manuscript submissions: 31 October 2024 | Viewed by 541

Special Issue Editors

Dr. Valeria Visco

E-Mail Website
Guest Editor
Department of Medicine and Surgery, University of Salerno, 84081 Baronissi, Italy
Interests: heart failure; arterial hypertension; telemonitoring; cardiovascular diseases; echocardiography
Special Issues, Collections and Topics in MDPI journals
Dr. Michele Ciccarelli

E-Mail Website
Guest Editor
Department of Medicine and Surgery, University of Salerno, 84081 Baronissi, Italy
Interests: molecular and clinical cardiology; new approaches for treatment of cardiovascular diseases
Special Issues, Collections and Topics in MDPI journals
Dr. Costantino Mancusi

E-Mail Website
Guest Editor
Department of Advanced Biomedical Sciences, Federico II University of Naples, Via S. Pansini 5, 80131 Napoli, Italy
Interests: cardiovascular disease; hypertension; heart failure
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

This Special Issue aims to provide a comprehensive overview of the latest advancements, research findings, and clinical perspectives in the field. Hypertension and cardiovascular disease continue to be significant health concerns worldwide, necessitating continuous updates and insights into their diagnosis, management, and prevention.

This Special Issue invites original research articles, review papers, and case studies that address various aspects of hypertension and cardiovascular disease within the clinical scope. We welcome submissions focusing on emerging diagnostic techniques, novel treatment approaches, risk assessment models, and preventive strategies. Additionally, articles exploring the impact of lifestyle modifications, pharmacological interventions, and personalized medicine in managing hypertension and cardiovascular disease are encouraged.

Authors are encouraged to contribute articles that shed light on the pathophysiology, epidemiology, and genetic factors associated with these conditions. Furthermore, we encourage submissions that explore the intersection between hypertension, cardiovascular disease, and other comorbidities such as diabetes, obesity, and renal disorders.

By bringing together diverse perspectives and up-to-date research, this Special Issue aims to enhance our understanding of hypertension and cardiovascular disease and contribute to improved patient care and outcomes.

Dr. Valeria Visco
Dr. Michele Ciccarelli
Dr. Costantino Mancusi
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • hypertension management
  • cardiovascular risk assessment
  • novel antihypertensive therapies
  • hypertension in pregnancy
  • hypertensive emergencies
  • cardiovascular disease prevention
  • pharmacological interventions for cardiovascular disease

Published Papers (1 paper)

Order results
Result details
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:

Research

11 pages, 252 KiB  
Article
Validation of the Novel Web-Based Application HUMTELEMED for a Comprehensive Assessment of Cardiovascular Risk Based on the 2021 European Society of Cardiology Guidelines
by Matteo Landolfo, Francesco Spannella, Alessandro Gezzi, Federico Giulietti, Lucia Sabbatini, Isabella Bari, Romina Alessandroni, Angelica Di Agostini, Paolo Turri, Francesco Alborino, Lorenzo Scoppolini Massini and Riccardo Sarzani
J. Clin. Med. 2024, 13(8), 2295; https://doi.org/10.3390/jcm13082295 - 16 Apr 2024
Viewed by 415
Abstract
Background and aims: SCORE2/SCORE2-OP cardiovascular risk (CVR) charts and online calculators do not apply to patients with comorbidities, target organ damage, or atherosclerotic cardiovascular disease, for whom the assessment relies on the conventional consultation of the 2021 ESC guidelines (qualitative approach). To simplify [...] Read more.
Background and aims: SCORE2/SCORE2-OP cardiovascular risk (CVR) charts and online calculators do not apply to patients with comorbidities, target organ damage, or atherosclerotic cardiovascular disease, for whom the assessment relies on the conventional consultation of the 2021 ESC guidelines (qualitative approach). To simplify the CVR evaluation, we developed an integrated multi-language and free-to-use web application. This study assessed the agreement between the conventional method versus our web app. Methods: A cross-sectional study was carried out on 1306 consecutive patients aged 40+ years referred to our center for the diagnosis and management of hypertension and dyslipidemia. Two double-blind operators performed the CVR assessment and classified each patient into low–moderate-, high-, and very-high-risk categories by using the conventional method (SCORE2/SCORE2-OP charts and consultation of the 2021 ESC guidelines) and the web app. The Kappa statistics were used to compare the two methods. Results: The mean age was 60.3 ± 11.9 years, with male prevalence (51.4%). Patients in primary prevention were 77.0%. According to the SCORE2/SCORE2-OP charts and 2021 ESC guideline consultation, the CVR was low–moderate in 18.6% (n° 243), high in 36.8% (n° 480), and very high in 44.6% (n° 583). According to the web app, individual CVR was low–moderate in 19.5% (n° 255), high in 35.4% (n° 462), and very high in 45.1% (n° 589). The two methods strongly agreed (Kappa = 0.960, p < 0.001), with a 97.5% concordance. Conclusions: our application has excellent reliability in a broad “real life” population and may help non-expert users and busy clinicians to assess individual CVR appropriately, representing a free-to-use, simple, time-sparing and widely available alternative to the conventional CVR evaluation using SCORE2/SCORE2-OP and 2021 ESC guideline charts. Full article
(This article belongs to the Special Issue Hypertension and Cardiovascular Disease: Clinical Updates and Perspectives)
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
 
Displaying articles 1-1
Back to TopTop